Skip to main content
. Author manuscript; available in PMC: 2020 May 24.
Published in final edited form as: Circ Res. 2019 May 24;124(11):1520–1535. doi: 10.1161/CIRCRESAHA.118.313568

Figure 3:

Figure 3:

Goals of Treatment in heart failure with preserved ejection fraction (HFpEF) BP= blood pressure; CAD= coronary artery disease; PDE-5 inhibitors= phosphodiestrase-5 inhibitors; SLGT-2 inhibitors= Sodium-glucose cotransporter-2 inhibitors